ArticleBMC oral health2025
Antibacterial effects and mechanisms of graphene oxide loaded on TiO
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Microfluidics-based engineered silver nanoparticles to control growth and biofilm formation in bacterial pathogens causing dental infection.Scientific reports · 2026Article
- Graphene Oxide-Modified Titanium Dioxide Nanotubes Promote Schwann Cell Function and Neurotrophic Factor Expression.Journal of functional biomaterials · 2026Article
- Nano-Modified Titanium Implant Surfaces for the Prevention and Treatment of Peri-Implantitis: A Review.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPeri-implant inflammation is an important factor affecting the success rate of dental implants. Improving the antibacterial performance of implants is an effective method to prevent and treat peri-implant inflammation.
methodsIn this study, Graphene oxide (GO) was loaded onto Titanium (Ti) dioxide nanotubes (TNT) to produce a material with good antibacterial effects and biocompatibility. TNT was prepared through anodization, and GO-loaded TNT-modified Ti (TNT-GO) was synthesized through electrodeposition. The materials were characterized using scanning electron microscopy (SEM), Raman spectroscopy, X-ray diffraction (XRD), and atomic force microscopy (AFM). Standard plate counting assay, methyl thiazolyl tetrazolium (MTT) assay, and fluorescence staining were used to assess the antibacterial effects of the samples. Bacterial morphology observations were conducted to explore the antibacterial mechanisms via SEM, transmission electron microscopy (TEM), reactive oxygen species (ROS) assay, and lactate dehydrogenase (LDH) cytotoxicity assay. Cell proliferation and morphological observations of the materials were performed to test the biocompatibility of TNT-GO.
resultsThe characteristic peaks of graphene oxide on TNT-GO were detected by Raman spectra. The results of contact angle test and AFM show that TNT-GO had the greatest hydrophilicity and the largest surface roughness. When P. gingivalis was cultured on the sample surfaces, the TNT-GO demonstrated the lowest bacterial adhesion, with significantly disrupted bacterial morphology. Specifically, the bacterial cells exhibited collapsed and ruptured cell membranes, leakage of intracellular contents, reduced membrane density, and phospholipid extraction. The TNT-GO group also showed the highest release of LDH extracellularly and the greatest ROS generation. The results of CCK-8 show that there was no significant difference between TNT-GO group and Ti group. The results of adherent cells morphology observation show that human gingival fibroblasts on TNT-GO group were in fusiformis and irregular triangle shapes while human gingival fibroblasts on TNT group and Ti group were in round shapes.
conclusionsThe TNT-GO had good biocompatibility and a good antibacterial effect on Porphyromonas gingivalis. It can inhibit bacteria-derived soft tissue infections and bone resorption and may be a very promising implant material.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.